Clinical Trials Logo
  1. Home
  2. Healthy
  3. NCT05036122
  4. Details
NCT05036122 Clinical Trial

Estimating Blood [Lactate] Non-Invasively

Healthy Clinical Trial

Official title:
Validation of a Non-Invasive Instrument to Estimate Blood Lactate

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05036122
Other study ID # 21-000318
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date February 2025
Est. completion date December 2025

Study information
Verified date March 2024
Source Mayo Clinic
Contact Madeline S Reid
Phone 507-255-0007
Email Reid.Madeline@mayo.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to validate the LabClasp's ability to estimate blood [lactate].

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 50
Est. completion date December 2025
Est. primary completion date September 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria - Aim 1: - Subjects must be able to provide written consent. - Adults 18 years of age and older. - Nonsmokers. - No recent hospitalization (< 60 days). - Ability to perform high-intensity exercise. Inclusion Criteria - Aim 2: - Subjects must be able to provide written consent to be included in the research study. - Adults 18 years of age and older. - Nonsmokers. - Current ICU patient. - Have regular blood samples taken for [lactate] measurements. - Have one or more risk factors for sepsis. Exclusion Criteria - Aims 1 and 2: - History of, or active malignancy. - History of HIV with antiretroviral treatment. - Smokers. - Pregnancy.

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• LabClasp
Non-invasive device that estimates blood [lactate] from interstitial fluid via a proprietary algorithm. The device is placed between the first and second knuckle of a finger and gently applies slight pressure to extract interstitial fluid from the skin. Sensors within the device quickly estimate blood [lactate] and return a value to the subject via an accompanying tablet within 20 seconds.

Locations
Country Name City State
United States Mayo Clinic in Rochester Rochester Minnesota

Sponsors (1)
Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome
Type Measure Description Time frame Safety issue
Primary Blood [lactate] during incremental exercise Measured via venous blood and the LabClasp 1 day
Primary Blood [lactate] measurements in ICU patients Measured via venous blood and the LabClasp 1 day
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1